Dr. Scott Antoine\u2019s r\xe9sum\xe9 includes 24 years practicing as an Emergency Medicine Physician and six years practicing Functional Medicine. As you can appreciate, he has a wealth of knowledge and practice under his belt, and is well placed to provide an update on Coronavirus pathophysiology and the role of potential therapies in preventing and managing the condition.
\n\n*Key Highlights *
\n\n\u2022 How Antoine found his way from ER to Functional Medicine (1:45)
\n\u2022 The difficulty with examining the prevalence of Coronavirus (7:20)
\n\u2022 Pathophysiology update (14:30)
\n\u2022 Navigating therapies for Coronavirus (25:20)
\n\u2022 The potential of Methylene blue (29:35)
\n\u2022 The cytokine storm (35:50)
\n\u2022 What can we do to prevent and manage Coronavirus? (41:20)
\n\u2022 Special mention to quercetin (49:30)
\n\u2022 Stress-related considerations (53:30)
*Useful links and resources: *
\nLink to Dr. Scott Antoine\u2019s clinic: www.vinehealthcare.com
\nLink to Antoine\u2019s research \u2013 \u2018A Literature Review Supporting the Addition of Intravenous Methylene Blue, High-dose Intravenous Vitamin C, Intravenous Glutathione, and Nutraceuticals, to Standard Care for Hospitalized COVID-19 Patients\u2019 https://www.vinehealthcare.com/wp-content/uploads/2020/04/COVID-19-Novel-Therapeutics-A-Comprehensive-Review-of-the-Literature.pdf
\nLink to article - \u2018Coronavirus (COVID-19), First Indication of Efficacy of Gene-Eden-VIR/Novirin in SARS-CoV-2 Infections\u2019 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146686/
\nLink to article \u2013 \u2018A cohort of cancer patients with no reported cases of SARS-CoV-2 infection: the possible preventive role of Methylene Blue\u2019 https://riviste.fupress.net/index.php/subs/article/view/888
\nLink to article \u2013 \u2018Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths\u2019 https://www.mdpi.com/2072-6643/12/4/988
\nLink to article \u2013 \u2018A new clinical trial to test high-dose vitamin C in patients with COVID-19\u2019 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137406/